* Rapid Micro Biosystems Inc RPID.OQ RPID.O is expected
to show a rise in quarterly revenue when it reports results
* The Lowell Massachusetts-based company is expected to
report a
17.1% increase in revenue to $5.55 million from $4.74 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* Refinitiv's mean analyst estimate for Rapid Micro
Biosystems
Inc is for a loss of 31 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Rapid Micro
Biosystems Inc is $5.88, above its last closing price
of $1.03.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.35 -0.35 -0.33 Beat 5.7
Mar. 31 2023 -0.37 -0.36 -0.32 Beat 12.3
Dec. 31 2022 -0.34 -0.36 -0.39 Missed -8.3
Sep. 30 2022 -0.37 -0.37 -0.38 Missed -3.6
Jun. -0.33 -0.32 -0.31 Beat 2.4
30 2022
Mar. 31 2022 -0.34 -0.33 -0.35 Missed -4.5
Dec. 31 2021 -0.24 -0.28 -0.35 Missed -25
Sep. 30 2021 -0.38 -0.38 -0.63 Missed -67.3
This summary was machine generated November 1 at 19:32 GMT. All
figures in US dollars unless otherwise stated